Program (2019)
The program features over 900 rapid-fire presentations offered in more than 100 sessions throughout the five-day event. Click on the day below to review the sessions, then click on the session number to see a listing of presentations and speakers within a session.

  View/Search/Print Complete 2019 Program Brochure in PDF
View/Print Entire 2019 Program

Program Outline at a Glance

TUESDAY PROGRAMS
Program A:(Sessions 1-8) 6:45 A.M. – 6:00 P.M. - 10 CME CREDIT HOURS
Progress In The Treatment Of Diseases Of Heart Valves, And Coronary Arteries And Thoracic And Abdominal Aortic Diseases
Location:Grand Ballroom East, 3rd Floor
 
Program B:(Sessions 9-16) 6:40 A.M. – 6:00 P.M. - 10 CME CREDIT HOURS
Progress In Vascular Robotics, Guidance Systems, Simulation And Laparoscopy; New Developments In Carotid Disease, Acute Strokes; And Their Treatments; Abdominal Aortic Branch Diseases And Their Treatments; New Concepts, Artificial Intelligence And Telemedicine; Vascular Branding, Recognition And Boards; Open Vascular Surgery And Progress In The Treatment Of Coarctations And Mid-Aortic Syndrome
Location:Grand Ballroom West, 3rd Floor
 
Program C-1:(Sessions 17-18) 7:00 A.M. – 12:00 P.M. - 4.5 CME CREDIT HOURS
Management Of Pulmonary Embolism: The Ultimate Team Approach
Course Leader: Michael R. Jaff, DO
Location:Trianon Ballroom, 3rd Floor
 
Program C-2:(Sessions 19-20) 1:00 P.M. – 3:00 P.M. - 2 CME CREDIT HOURS
Introduction To Vascular Malformations
Course Leaders:
Wayne F. Yakes, MD
Krassi Ivancev, MD, PhD
Robert L. Vogelzang, MD
Location:Trianon Ballroom, 3rd Floor
 
Program C-3:(Sessions 21-22) 3:00 P.M. – 6:00 P.M. - 3 CME CREDIT HOURS
Hot New Topics In Lower Extremity Occlusive Disease Treatment
Location:Trianon Ballroom, 3rd Floor
 
WEDNESDAY PROGRAMS
Program D:(Sessions 23-30) 6:40 A.M. – 6:15 P.M. - 10.5 CME CREDIT HOURS
Progress In Lower Extremity Occlusive Disease And Its Treatments
Location:Grand Ballroom East, 3rd Floor
 
Program E:(Sessions 31-38) 6:40 A.M. – 6:02 P.M. - 10.25 CME CREDIT HOURS
Advances In Medical Treatments, New Drugs, Anti-Atherogenic And Anti-Hypertensive Treatments; Management Of Endoleaks And Complications; Recorded Live Cases; A Tribute And Assorted Issues Of Interest; Outpatient Vascular Treatment And Ethical Issues; Topics Related To The FDA, SVS, VQI, Costs And Reimbursement And The Value Of Vascular Surgeons
Location:Grand Ballroom West, 3rd Floor
 
Program F:(Sessions 39-46) 6:40 A.M. – 6:00 P.M. - 10.25 CME CREDIT HOURS
More New Developments In Thoracic Aortic Disease, Aortic Dissections, TAAAs, Juxta- And Pararenal AAAs, Parallel Grafts, Fenestrated And Branched EVAR (F/B/EVAR), Multilayer Bare Stents, Infrarenal AAAs And Standard EVAR And Hot New Aortic And Carotid Topics
Location:Trianon Ballroom, 3rd Floor
 
THURSDAY PROGRAMS
Program G:(Sessions 47-54) 6:45 A.M. – 6:02 P.M. - 10 CME CREDIT HOURS
Exciting New Or Updated Techniques, Concepts And Devices; Advances In F/B/EVAR And Parallel Grafts For Complex AAAs; Tribute To Our Military; New Developments In The Treatment Of Ruptured AAAs And TAAAs; More New Developments In New Or Improved Devices, Techniques And Concepts, And Radiation Safety
Location:Grand Ballroom East, 3rd Floor
 
Program H:(Sessions 55-62) 6:45 A.M. – 5:52 P.M. - 9.75 CME CREDIT HOURS
New Or Improved Devices For Standard EVAR, EVAS And More Complex AAAs; Repair Of TAAAs, The Ascending Aortic Arch And The Descending Aorta (TEVAR): New Devices For Treating Lower Extremity Lesions By Endovascular Or Open Techniques; Updates On Endoanchors And Improvements In Their Usage; And New Or Improved Devices For Removing Clot And Occluding Blood Vessels Endovascularly
Location:Grand Ballroom West, 3rd Floor
 
Program I:(Sessions 63-70) 7:00 A.M. – 6:05 P.M. - 10.5 CME CREDIT HOURS
Superficial Venous Disease
Course Leaders:
Jose I. Almeida, MD, RPVI, RVT
Lowell S. Kabnick, MD, RPhS
Kenneth Ouriel, MD, MBA
Thomas W. Wakefield, MD
Location:Trianon Ballroom, 3rd Floor
 
FRIDAY PROGRAMS
Program J:(Sessions 71-78) 6:40 A.M. – 5:42 P.M. - 9.75 CME CREDIT HOURS
New Developments In The Prevention And Treatment Of Spinal Cord Ischemia (SCI) With TEVAR And TAAA Repairs; Carotid Disease And Treatment Related Topics: New And Improved Devices And Techniques (TCAR And Mesh Covered Stents), Medical Treatment, Influence On Cognition, History Of CAS, Timing Of CEA And CAS, Management Of Asymptomatic Carotid Stenosis (ACS), CAS Versus CEA, Improved Carotid Techniques, RCT Updates, Continuing Controversies; Endo Treatment For Erectile Dysfunction; Carotid Patch Infections And Aneurysms; Percutaneous Closure Devices And Wound Care
Location:Grand Ballroom East, 3rd Floor
 
Program K:(Sessions 79-86) 7:00 A.M. – 5:52 P.M. - 9.5 CME CREDIT HOURS
New Developments In The Treatment Of Popliteal Diseases And Aneurysms; Advances In Treating Arterial And Graft Infections; Improvements In: Vascular Imaging And Hybrid Treatment Suites; Thoracic Outlet Syndrome Treatments; Recorded Live Complex Endovascular Cases From Münster, Germany And The Mayo Clinic; Updates On Medical Treatments And Treatment Of Rare Or Unusual Vascular Diseases And Vascular Trauma
Location:Grand Ballroom West, 3rd Floor
 
Program L:(Sessions 87-94) 7:00 A.M. – 6:00 P.M. - 10.5 CME CREDIT HOURS
Deep Venous Disease
Course Leaders:
Jose I. Almeida, MD, RVT, RPVI
Lowell S. Kabnick, MD, RPhS
Kenneth Ouriel, MD, MBA
Thomas W. Wakefield, MD
Location:Trianon Ballroom, 3rd Floor
 
SATURDAY PROGRAMS
Program M:(Sessions 95-98) 7:00 A.M. – 12:25 P.M. - 5.25 CME CREDIT HOURS
Topics Too Important Or Too Hot To Miss: Related To Lower Extremity; Aortic; And Carotid Diseases And Their Treatment
Location:Grand Ballroom East, 3rd Floor
 
Program N:(Sessions 99-103) 8:00 A.M. – 3:40 P.M. - 7 CME CREDIT HOURS
Improving Outcomes In Hemodialysis Access
Course Leaders: Anton N. Sidawy, MD, MPH and Larry A. Scher, MD
Location:Grand Ballroom West, 3rd Floor
 
Program O:(Sessions 104-109) 8:00 A.M. – 3:50 P.M. - 7.5 CME CREDIT HOURS
Multidisciplinary Acute Stroke Management
Course Leader: Allan L. Brook, MD
Location:Murray Hill Suites East & West, 2nd Floor
 

Tuesday, November 19, 2019 - Program Details

Open All 2019 Tuesday Sessions
COMBINED PROGRAM FOR VASCULAR SURGERY, INTERVENTIONAL RADIOLOGY, CARDIOLOGY AND CARDIOTHORACIC SURGERY

6:00AM - General Registration - Rhinelander Gallery, 2nd Floor
6:00AM - Faculty Registration - Morgan Suite - 2nd Floor
6:15AM - Continental Breakfast - Rhinelander Gallery, 2nd Floor

PROGRAMS A, B, C-1, C-2 AND C-3 ARE CONCURRENT TUESDAY PROGRAMS
PROGRAM A (SESSIONS 1-8 - PROGRESS IN THE TREATMENT OF DISEASES OF HEART VALVES, CORONARY ARTERIES AND THORACIC AND ABDOMINAL AORTIC DISEASES; 6:40 A.M. to 6:00 P.M.)
Location: Grand Ballroom East, 3rd Floor
SESSION 1: PROGRESS IN THE TREATMENT OF ASCENDING AORTIC DISEASE, TRANSCATHETER VALVE REPLACEMENT AND CORONARY ARTERY STENTING
SESSION 2: PROGRESS IN THE TREATMENT OF AORTIC ARCH LESIONS AND AORTIC DISSECTIONS
SESSION 3: PROGRESS IN THE ENDOVASCULAR TREATMENT OF AORTIC DISSECTIONS: PETTICOAT, STABILISE, FLIRT, FENESTRATIONS AND TEVAR’S EFFECTS ON THE HEART
SESSION 4: MORE NEW DEVELOPMENTS IN THE TREATMENT OF TBADs, THORACIC AORTIC DISEASE AND THORACOABDOMINAL ANEURYSMS (TAAAs)
SESSION 5: NEW DEVELOPMENTS IN ABDOMINAL AORTIC ANEURYSM (AAA) TREATMENT, EVAR AND EVAS (ENDOVASCULAR ANEURYSM SEALING)
SESSION 6: MORE ABOUT AAAs AND EVAR; THE NICE GUIDELINES AND REACTIONS TO THEM
SESSION 7: MORE NEW DEVELOPMENTS IN THE TREATMENT OF AORTIC DISSECTIONS AND THORACIC AORTIC PATHOLOGY
SESSION 8: MORE NEW DEVELOPMENTS RELATING TO TEVAR AND TBADs: CAUSES AND PREVENTION OF STROKE COMPLICATIONS; CONTROVERSIES OVER THE NEED FOR TEVAR IN SOME OR ALL ACUTE UNCOMPLICATED TBAD PATIENTS, AND OVER THE EXTENT OF TEVAR COVERAGE
PROGRAM B (SESSIONS 9-16 -PROGRESS IN VASCULAR ROBOTICS, GUIDANCE SYSTEMS, SIMULATION AND LAPAROSCOPY; NEW DEVELOPMENTS IN CAROTID DISEASE, ACUTE STROKES; AND THEIR TREATMENTS; ABDOMINAL AORTIC BRANCH DISEASES AND THEIR TREATMENTS; NEW CONCEPTS, ARTIFICIAL INTELLIGENCE AND TELEMEDICINE; VASCULAR BRANDING, RECOGNITION AND BOARDS; OPEN VASCULAR SURGERY AND PROGRESS IN THE TREATMENT OF COARCTATIONS AND MID-AORTIC SYNDROME; 6:40 A.M. to 6:00 P.M.)
Location: Grand Ballroom West, 3rd Floor
SESSION 9: PROGRESS IN VASCULAR ROBOTICS, GUIDANCE SYSTEMS, SIMULATION AND LAPAROSCOPY
SESSION 10: NEW DEVELOPMENTS IN THE MANAGEMENT OF CAROTID DISEASE: UNRESOLVED CONTROVERSIES
SESSION 11: MORE NEW DEVELOPMENTS IN CAROTID DISEASE AND ITS TREATMENT; PROGRESS IN THE INTERVENTIONAL MANAGEMENT OF ACUTE STROKES (5 AND SOME 4-MINUTE SHORT SUMMARY [SS] TALKS)
SESSION 12: PROGRESS IN THE TREATMENT OF AORTO-ILIAC AND ILIAC OCCLUSIVE DISEASE
SESSION 13: NEW OR UPDATED CONCEPTS AND TECHNIQUES; IMPORTANCE OF ARTIFICIAL INTELLIGENCE (AI) IN VASCULAR TREATMENT (5 AND ONE 4-MINUTE SHORT SUMMARY [SS] TALKS)
SESSION 14: VASCULAR SURGERY BRANDING, RECOGNITION, TRAINING AND GOVERNING BODIES (BOARD AND RESIDENCY REVIEW COMMITTEE [RRC])
SESSION 15: NEW DEVELOPMENTS IN THE TREATMENT OF RENAL AND VISCERAL ARTERY DISEASE (5 AND SOME 4-MINUTE SHORT SUMMARY [SS] TALKS)
SESSION 16: UPDATE ON OPEN SURGICAL AND HYBRID PROCEDURES; NEW DEVELOPMENTS IN THE TREATMENT OF AORTIC COARCTATION
PROGRAM C-1 (SESSIONS 17-18 - MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE TEAM APPROACH; 7:00 A.M. to 12:00 P.M.)
Location: Trianon Ballroom, 3rd Floor
SESSION 17: MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE TEAM APPROACH - PART 1
SESSION 18: MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE TEAM APPROACH – PART 2
PROGRAM C-2 (SESSIONS 19-20 - INTRODUCTION TO VASCULAR MALFORMATIONS; 1:00 P.M. to 3:00 P.M.)
Location: Trianon Ballroom, 3rd Floor
SESSION 19: INTRODUCTION TO VASCULAR MALFORMATIONS
SESSION 20: HEAD AND NECK VASCULAR MALFORMATION MANAGEMENT; HIGH-FLOW AVMs MANAGEMENT ISSUES
PROGRAM C-3 (SESSIONS 21-22 - HOT NEW TOPICS IN LOWER EXTREMITY OCCLUSIVE DISEASE TREATMENT; 3:00 P.M. to 6:00 P.M.)
Location: Trianon Ballroom, 3rd Floor
SESSION 21: HOT NEW SHORT SUMMARY TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE AND CLTI (ALL TALKS ARE 4 ¾ MINUTES)
SESSION 22: MORE HOT NEW SHORT SUMMARY TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE AND CLTI (ALL TALKS ARE 4 ¾ MINUTES)

Wednesday, November 20, 2019 - Program Details

Open All 2019 Wednesday Sessions

6:00AM - General Registration - Rhinelander Gallery, 2nd Floor
6:00AM - Faculty Registration - Morgan Suite - 2nd Floor
6:15AM - Continental Breakfast - Rhinelander Gallerly, 2nd Floor

PROGRAMS D, E AND F ARE CONCURRENT WEDNESDAY PROGRAMS
PROGRAM D (SESSIONS 23-30 - PROGRESS IN LOWER EXTREMITY OCCLUSIVE DISEASE AND ITS TREATMENTS; 6:40 A.M. to 6:15 P.M.)
Location: Grand Ballroom East, 3rd Floor
SESSION 23: GENERALITIES IN THE ENDOVASCULAR AND OPEN TREATMENT OF LOWER EXTREMITY OCCLUSIVE LESIONS
SESSION 24: PROGRESS IN STENT BASED TREATMENTS, ATHERECTOMY AND LITHOPLASTY (LITHOTRIPSY) FOR LOWER EXTREMITY OCCLUSIVE LESIONS
SESSION 25: NEW DEVELOPMENTS IN LOWER EXTREMITY RELATED TOPICS: DOWNSIDE OF DCBs: THE PACLITAXEL COATED DEVICES INCREASE MORTALITY ISSUE
SESSION 26: NEW DEVELOPMENTS IN DRUG COATED BALLOONS (DCBs) AND OTHER DEVICES FOR TREATING LOWER EXTREMITY OCCLUSIVE LESIONS; RANDOMIZED CONTROLLED TRIALS (RCTs) AND BTK TREATMENTS (5- AND 4-MINUTE SHORT SUMMARY [SS] TALKS)
SESSION 27: EXOTIC AND EXTREME NEW TREATMENTS FOR VERY DISTAL LOWER EXTREMITY OCCLUSIVE DISEASE CAUSING SEVERE CHRONIC LIMB THREATENING ISCHEMIA (CLTI): HOW TO SAVE THE “NO OPTION FOR TREATMENT” LIMB AND THE “DESERT FOOT” WITH NO PATENT TARGET ARTERIES
SESSION 28: NEW DEVELOPMENTS IN LOWER EXTREMITY IN STENT RESTENOSIS (ISR); SELF-EXPANDING STENT-GRAFTS (VIABAHN); HEPARIN BONDING; ARTERIAL CALCIFICATION; UNUSUAL LOWER EXTREMITY STENTS AND THE IMPORTANCE OF HEPARIN BONDING TO PTFE GRAFTS AND DCB INFLATION PRESSURES (SEE ALSO SESSION 59)
SESSION 29: UPDATES ON LOWER EXTREMITY CLTI GUIDELINES, RCTs AND FOOT PERFUSION INDICATORS
SESSION 30: NEW DEVELOPMENTS IN THE TREATMENT OF LOWER EXTREMITY INTERMITTENT CLAUDICATION (IC) AND ACUTE LIMB ISCHEMIA (ALI)
PROGRAM E (SESSIONS 31-38 - ADVANCES IN MEDICAL TREATMENTS, NEW DRUGS, ANTI-ATHEROGENIC AND ANTI-HYPERTENSIVE TREATMENTS; MANAGEMENT OF ENDOLEAKS; LIVE RECORDED CASES; A TRIBUTE AND ASSORTED ISSUES; OUTPATIENT VASCULAR TREATMENT AND ETHICS; TOPICS RELATED TO THE SVS, THE VQI, THE FDA, VALUE OF A VASCULAR SURGEON, COSTS AND REIMBURSEMENT; 6:40 A.M. to 6:02 P.M.)
Location: Grand Ballroom West, 3rd Floor
SESSION 31: ADVANCES IN MEDICAL TREATMENTS, ANTI-ATHEROGENIC DRUGS AND CARDIAC AND CORONARY ARTERY RISK EVALUATION IN PATIENTS WITH VASCULAR DISEASE
SESSION 32: MORE ADVANCES IN MEDICAL TREATMENTS; MORE ABOUT NEW DRUGS; STEM CELL TREATMENTS; CATHETER BASED TREATMENTS FOR RESISTANT HYPERTENSION
SESSION 33: PROGRESS IN MANAGING COMPLICATIONS AND ENDOLEAKS AFTER EVAR AND TEVAR
SESSION 34: RECORDED LIVE CHALLENGING AND COMPLEX CASES FROM LINC AND LEIPZIG
SESSION 35: CHALLENGING RECORDED LIVE CASES AND THOSE EMPLOYING INNOVATIVE TECHNIQUES
SESSION 36: TRIBUTE TO A VALUED PARTNER; IMPORTANT ISSUES RELATED TO VASCULAR PRACTICE AND VASCULAR SURGEONS
SESSION 37: ISSUES RELATED TO VASCULAR OUTPATIENT CENTERS, OFFICE BASED LABS AND MEDICAL ETHICS
SESSION 38: TOPICS RELATED TO THE FDA, VALUE OF A VASCULAR SURGEON, VASCULAR PRACTICE, THE SVS, VQI AND GOVERNMENTAL REGULATIONS AND REIMBURSEMENT
PROGRAM F (SESSIONS 39-46 - MORE NEW DEVELOPMENTS IN THORACIC AORTIC DISEASE, AORTIC DISSECTIONS, TAAAs, JUXTA- AND PARARENAL AAAs, PARALLEL GRAFTS, FENESTRATED AND BRANCHED EVAR (F/B/EVAR), MULTILAYER BARE STENTS, INFRARENAL AAAs AND STANDARD EVAR AND HOT NEW AORTIC AND CAROTID TOPICS; 6:40 A.M. to 6:00 P.M.)
Location: Trianon Ballroom, 3rd Floor
SESSION 39: MORE TOPICS RELATED TO NEW DEVELOPMENTS IN TREATING AORTIC DISSECTIONS AND ITS COMPLICATIONS
SESSION 40: MORE NEW DEVELOPMENTS RELATED TO THE ASCENDING AORTA, AORTIC ARCH, F/B/TEVAR AND PARALLEL GRAFTS FOR TREATMENT OF LESIONS IN OR NEAR THE AORTIC ARCH
SESSION 41: MORE ABOUT JUXTA- AND PARARENAL AAAs, TAAAs, F/B/EVAR AND PARALLEL GRAFTS (CHIMNEY EVAR [Ch/EVAR])
SESSION 42: UPDATE ON MULTILAYER FLOW MODULATING BARE STENTS FOR TREATING ANEURYSMS AND DISSECTIONS; NEW DEVELOPMENTS IN TREATING ILIAC ANEURYSMS AND REVASCULARIZING HYPOGASTRIC ARTERIES
SESSION 43: INTERESTING NEW DEVELOPMENTS IN STANDARD EVAR AND INFRARENAL AAAs: ACCEPTABLE NECK ANATOMY; NEW GUIDELINES; AAA SAC THROMBUS AND SHRINKAGE; NEW CLASSIFICATION SYSTEM; EFFECT OF STEROIDS ON EVAR
SESSION 44: MORE NEW DEVELOPMENTS IN AAA PATHOGENESIS, NATURAL HISTORY AND TREATMENT
SESSION 45: SHORT HOT NEW TOPICS RELATED TO AORTIC DISEASES AND THEIR TREATMENT (4 ¾- MINUTE FAST PACED TALKS)
SESSION 46: MORE SHORT HOT NEW TOPICS RELATED TO AORTIC AND CAROTID DISEASES AND THEIR TREATMENT (4 ¾-MINUTE FAST PACED TALKS)

Thursday, November 21, 2019 - Program Details

Open All 2019 Thursday Sessions

6:00AM - General Registration - Rhinelander Gallery, 2nd Floor
6:00AM - Faculty Registration - Morgan Suite - 2nd Floor
6:15AM - Continental Breakfast - Rhinelander Gallery, 2nd Floor

PROGRAMS G, H AND I ARE CONCURRENT THURSDAY PROGRAMS
PROGRAM G (SESSIONS 47-54 - EXCITING NEW OR UPDATED TECHNIQUES, CONCEPTS AND DEVICES; ADVANCES IN F/B/EVAR AND PARALLEL GRAFTS FOR COMPLEX AAAs; TRIBUTE TO OUR MILITARY; NEW DEVELOPMENTS IN THE TREATMENT OF RUPTURED AAAs AND TAAAs; MORE NEW DEVELOPMENTS IN NEW OR IMPROVED DEVICES, TECHNIQUES AND CONCEPTS, AND RADIATION SAFETY; 6:45 A.M. to 6:02 P.M.)
Location: Grand Ballroom East, 3rd Floor
SESSION 47: EXCITING NEW OR UPDATED CONCEPTS, TECHNIQUES OR DEVICES
SESSION 48: NEW DEVELOPMENTS IN FENESTRATED AND BRANCHED EVAR (F/B/EVAR AND PARALLEL GRAFTS FOR COMPLEX AAAs AND TAAAs)
SESSION 49: MORE ABOUT F/B/EVAR AND PARALLEL GRAFTS TO TREAT COMPLEX AAAs AND TAAAs
SESSION 50: A TRIBUTE TO OUR MILITARY AND SERVICE PHYSICIANS: MILITARY HISTORY, CONTROL AND TREATMENT OF MILITARY AND CIVILIAN VASCULAR INJURIES, CURRENT COMBAT CONDITIONS AND VALUE OF A TISSUE ENGINEERED VASCULAR GRAFT(6-MINUTE TALKS)
SESSION 51: NEW DEVELOPMENTS IN THE TREATMENT OF RUPTURED ABDOMINAL AORTIC ANEURYSMS (RAAAs)
SESSION 52: MORE NEW DEVELOPMENTS IN THE TREATMENT OF RAAAs AND RUPTURED JUXTA- AND PARARENAL AAAs AND TAAAs
SESSION 53: EXCITING NEW OR IMPROVED TECHNIQUES, CONCEPTS AND DEVICES; UPDATES ON EVOLVING ENDOVASCULAR TREATMENTS
SESSION 54: MORE ABOUT NEW CONCEPTS, DEVICES AND TECHNIQUES; PROGRESS IN RADIATION SAFETY
PROGRAM H (SESSIONS 55-62 - NEW OR IMPROVED DEVICES FOR: STANDARD EVAR, EVAS AND MORE COMPLEX AAAs; REPAIR OF TAAAs, THE AORTIC ARCH AND THE DESCENDING AORTA (TEVAR): NEW DEVICES FOR TREATING LOWER EXTREMITY LESIONS BY ENDOVASCULAR OR OPEN TECHNIQUES; UPDATES ON ENDOANCHORS AND IMPROVEMENTS IN THEIR USAGE; AND NEW OR IMPROVED DEVICES FOR REMOVING CLOT AND OCCLUDING BLOOD VESSELS ENDOVASCULARLY; 6:45 A.M. to 5:52 P.M.)
Location: Grand Ballroom West, 3rd Floor
SESSION 55: NEW OR IMPROVED DEVICES FOR STANDARD INFRARENAL EVAR PROCEDURES AND STRATEGIES FOR OPEN AAA REPAIR TRAINING
SESSION 56: MORE NEW OR UPDATED INFORMATION ABOUT NON-STANDARD DEVICES FOR EVAR OR ENDOVASCULAR ANEURYSM SEALING (EVAS) (TALKS ARE 4 3/4 OR 5 MINUTES)
SESSION 57: NEW OR UPDATED ENDOVASCULAR DEVICES FOR TREATING ANEURYSMS AND OTHER LESIONS IN OR NEAR THE AORTIC ARCH (5-MINUTE TALKS)
SESSION 58: NEW OR UPDATED ENDOVASCULAR DEVICES FOR TREATING DESCENDING AORTIC LESIONS (TEVAR) AND TAAAs (5-MINUTE TALKS)
SESSION 59: NEW OR UPDATED INFORMATION ON LOWER EXTREMITY PROSTHETIC GRAFTS OR STENT-GRAFTS FOR TREATMENT OF OCCLUSIVE DISEASE AND OTHER USES; VALUE OF HYBRID GRAFTS (PARTIALLY STENTED) FOR RENAL-VISCERAL DEBRANCHING (SEE ALSO SESSION 28)
SESSION 60: NEW OR UPDATED DEVICES FOR LOWER EXTREMITY TREATMENTS: STENTS, BALLOONS, TACKS AND ATHERECTOMY DEVICES
SESSION 61: UPDATES ON ANCHORING DEVICES (ENDOANCHORS) TO PREVENT OR TREAT ENDOLEAKS WITH EVAR OR TO PREVENT DEVICE MIGRATION
SESSION 62: NEW OR IMPROVED DEVICES FOR REMOVING DISEASE RELATED OR IATROGENIC CLOT; NEW DEVICES FOR INTRA-ARTERIAL EMBOLIZATION (4 ¾- MINUTE TALKS)
PROGRAM I (SESSIONS 63-70 - SUPERFICIAL VENOUS DISEASE; 7:00 A.M. to 6:05 P.M.)
Location: Trianon Ballroom, 3rd Floor
SESSION 63: VENOUS CLINICAL EXAMINATION AND HEMODYNAMICS
SESSION 64: VENOUS IMAGING TECHNIQUES
SESSION 65: SUPERFICIAL VEIN TREATMENT STRATEGIES AND TECHNIQUES
SESSION 66: THERMAL AND NON-THERMAL ABLATION
SESSION 67: SPIDER VEINS, TRUNCAL VEINS, TRIBUTARY VEINS, EXOTIC VEIN TREATMENT
SESSION 68: VENOUS SOCIETAL AND GOVERNANCE
SESSION 69: TRUNCAL ABLATION: TIPS AND TRICKS (VIDEOS)
SESSION 70: VENOUS CLINICAL TRIALS, LYMPHATIC, SUPERFICIAL VEIN TREATMENT STRATEGIES

Friday, November 22, 2019 - Program Details

Open All 2019 Friday Sessions

6:00AM - General Registration - Rhinelander Gallery - 2nd Floor
6:00AM - Faculty Registration - Morgan Suite - 2nd Floor
6:15AM - Continental Breakfast - Rhinelander Gallery, 2nd Floor

PROGRAMS J, K AND L ARE CONCURRENT FRIDAY PROGRAMS
PROGRAM J (SESSIONS 71-78 - NEW DEVELOPMENTS IN THE PREVENTION AND TREATMENT OF SPINAL CORD ISCHEMIA (SCI) WITH TEVAR AND TAAA REPAIRS; CAROTID DISEASE AND TREATMENT RELATED TOPICS: NEW AND IMPROVED DEVICES AND TECHNIQUES (TCAR AND MESH COVERED STENTS), MEDICAL TREATMENT, INFLUENCE ON COGNITION, HISTORY OF CAS, TIMING OF CEA AND CAS, MANAGEMENT OF ASYMPTOMATIC CAROTID STENOSIS (ACS), CAS VERSUS CEA, IMPROVED CAROTID TECHNIQUES, RC TRIAL UPDATES, AND DEBATES ON CONTINUING CONTROVERSIES; UPDATE ON ENDO TREATMENT FOR ERECTILE DYSFUNCTION AND CAROTID PATCH INFECTIONS AND ANEURYSMS; NEW DEVELOPMENTS IN PERCUTANEOUS CLOSURE DEVICES AND WOUND CARE; 6:40 A.M. to 5:42 P.M.)
Location: Grand Ballroom East, 3rd Floor
SESSION 71: NEW DEVELOPMENTS IN THE PREVENTION AND TREATMENT OF SPINAL CORD ISCHEMIA (SCI) ASSOCIATED WITH TEVAR AND THE TREATMENT OF TAAAs (5-MINUTE TALKS)
SESSION 72: ADVANCES IN THE TREATMENT OF CAROTID STENOSIS: MESH COVERED STENTS FOR CAROTID ARTERY STENTING (CAS) AND UPDATE ON TRANSCERVICAL CAROTID ARTERY REVASCULARIZATION (TCAR) FOR CAS
SESSION 73: MORE CAROTID RELATED TOPICS: MORE ON TCAR; BEST MEDICAL TREATMENT (BMT) FOR CAROTID DISEASE AND BMT'S IMPACT ON INVASIVE TREATMENTS; THE EFFECT OF CAROTID DISEASE AND ITS TREATMENT ON COGNITION
SESSION 74: MORE CAROTID RELATED TOPICS: CONTROVERSIES OVER INVASIVE TREATMENTS OF ASYMPTOMATIC PATIENTS WITH CAROTID STENOSIS (ACS) AND OPTIMAL TIMING OF INVASIVE CAROTID TREATMENTS AFTER SYMPTOM ONSET
SESSION 75: NEW DEVELOPMENTS IN THE CAS VERSUS CEA CONTROVERSY; NEED FOR CEA/CAS WITH OTHER SURGERY; AND OTHER UNUSUAL BUT IMPORTANT CAROTID RELATED TOPICS AND A HISTORICAL NOTE ON CAS
SESSION 76: UPDATES ON THE COMPLETED AND ONGOING CAROTID RCTs AND THEIR PITFALLS; NEED FOR POST CEA/CAS SURVEILLANCE; IMPLICATIONS OF FILTER DEBRIS
SESSION 77: A CAROTID CONTROVERSY AND MORE CAROTID UPDATES; OTHER HOT NEW OR UPDATED TOPICS
SESSION 78: PERCUTANEOUS CLOSURE DEVICES: NEW DEVELOPMENTS IN ESTABLISHED DEVICES AND NEW DEVICES; ADVANCES IN WOUND CARE
PROGRAM K (SESSIONS 79-86 - NEW DEVELOPMENTS IN THE TREATMENT OF POPLITEAL DISEASES AND ANEURYSMS; ADVANCES IN TREATING ARTERIAL AND GRAFT INFECTIONS; IMPROVEMENTS IN: VASCULAR IMAGING AND HYBRID TREATMENT SUITES; THORACIC OUTLET SYNDROME TREATMENTS; RECORDED LIVE COMPLEX ENDOVASCULAR CASES FROM MÜNSTER, GERMANY AND THE MAYO CLINIC; UPDATES ON MEDICAL TREATMENTS, TREATMENT OF RARE OR UNUSUAL VASCULAR DISEASES AND VASCULAR TRAUMA;7:00 A.M. to 5:52 P.M.)
Location: Grand Ballroom West, 3rd Floor
SESSION 79: NEW DEVELOPMENTS IN POPLITEAL DISEASES AND THEIR TREATMENT: POPLITEAL ANEURYSMS, NON-ATHEROMATOUS DISEASES AND ENTRAPMENT SYNDROMES; VALUE OF DUPLEX AND OTHER IMAGING IN THEIR DIAGNOSIS
SESSION 80: NEW DEVELOPMENTS AND CONTROVERSIES IN THE OPTIMAL TREATMENT FOR INFECTED ARTERIES, AAAs, ARTERIAL GRAFTS AND ENDOGRAFTS
SESSION 81: ADVANCES IN IMAGING AND HYBRID OPERATING/PROCEDURE ROOMS
SESSION 82: CHALLENGING RECORDED LIVE CASES FROM MÜNSTER
SESSION 83: CHALLENGING RECORDED LIVE CASES FROM THE MAYO CLINIC
SESSION 84: NEW DEVELOPMENTS IN THE TREATMENT OF THORACIC OUTLET SYNDROMES (TOSs)
SESSION 85: IMPORTANT NEW DEVELOPMENTS IN MEDICAL AND ANTI-ATHEROGENIC AND ANTICOAGULANT DRUG TREATMENTS; UPDATES ON UNUSUAL DISEASES AND THEIR INTERVENTIONAL VASCULAR TREATMENT; MANAGEMENT OF TAVR ARTERIAL ACCESS COMPLICATIONS
SESSION 86: NEW DEVELOPMENTS IN THE MANAGEMENT OF VASCULAR TRAUMA: PROS AND CONS OF REBOA; ENDO VERSUS OPEN TREATMENTS
PROGRAM L (SESSIONS 87-94 - DEEP VENOUS DISEASE;7:00 A.M. to 6:00 P.M.)
Location: Trianon Ballroom, 3rd Floor
SESSION 87: PELVIC VENOUS DISORDERS, NUTCRACKER SYNDROME, CHRONIC VENOUS OCCLUSIONS, STRATEGIES TO DIAGNOSE AND INTERVENE
SESSION 88: ILIOCAVAL STENTS, STENT TRIALS AND STENT SURVEILLANCE
SESSION 89: MORE ON ILIOCAVAL STENTS, STENT PROBLEMS POST-IMPLANTATION, MEDICAL AND HYBRID TECHNIQUES TO REDUCE VENOUS HYPERTENSION
SESSION 90: STRATEGIES FOR CORRECTING SEVERE DEEP VENOUS OBSTRUCTION, VENOUS ULCERS AND NEW HORIZONS IN WOUND CARE
SESSION 91: CAVAL RECONSTRUCTION AND MORE FEMORAL AND ILIOCAVAL FLOW ISSUES
SESSION 92: SURGICAL AND INTERVENTIONAL MANAGEMENT STRATEGIES FOR THROMBOEMBOLIC EVENTS IN THE VENOUS SYSTEM
SESSION 93: MEDICAL MANAGEMENT STRATEGIES FOR THROMBOEMBOLIC EVENTS IN THE VENOUS SYSTEM I
SESSION 94: DEEP VEIN VALVE TECHNOLOGIES, CAVAL INTERRUPTION AND IVC FILTER COMPLICATIONS

Saturday, November 23, 2019 - Program Details

Open All 2019 Saturday Sessions

6:00AM - General Registration - 2nd Floor Promenade
6:00AM - Faculty Registration - Morgan Suite - 2nd Floor
6:30AM - Continental Breakfast - Grand Ballroom Foyer - 3rd Floor

PROGRAMS M, N AND O ARE CONCURRENT SATURDAY PROGRAMS
PROGRAM M (SESSIONS 95-98 - TOPICS TOO IMPORTANT OR TOO HOT TO MISS: RELATED TO LOWER EXTREMITY; AORTIC AND CAROTID DISEASES AND THEIR TREATMENT; 7:00 A.M. to 12:25 P.M.)
Location: Grand Ballroom East, 3rd Floor
SESSION 95: LOWER EXTREMITY TOPICS TOO IMPORTANT OR TOO HOT TO MISS (4 ¾-MINUTE TALKS)
SESSION 96: MORE LOWER EXTREMITY TOPICS TOO IMPORTANT OR TOO HOT TO MISS (4 ¾-MINUTE TALKS)
SESSION 97: AORTIC TOPICS TOO IMPORTANT OR TOO HOT TO MISS (4 ¾-MINUTE TALKS)
SESSION 98: AORTIC AND CAROTID TOPICS TOO IMPORTANT OR TOO HOT TO MISS (4 ¾-MINUTE TALKS)
PROGRAM N (SESSIONS 99-103 - IMPROVING OUTCOMES IN HEMODIALYSIS ACCESS; 8:00 A.M. to 3:40 P.M.)
Location: Grand Ballroom West, 3rd Floor
SESSION 99: IMPORTANT ISSUES IN HEMODIALYSIS ACCESS (7-MINUTE TALKS)
SESSION 100: OPTIMIZING OUTCOMES IN HEMODIALYSIS ACCESS (7-MINUTE TALKS)
SESSION 101: POLITICAL, ECONOMIC AND LEGAL ISSUES IN HEMODIALYSIS ACCESS (7-MINUTE TALKS)
SESSION 102: NEW TECHNOLOGIES AND CONCEPTS IN HEMODIALYSIS ACCESS (7-MINUTE TALKS)
SESSION 103: UPDATE ON CLINICAL CHALLENGES IN HEMODIALYSIS ACCESS (7-MINUTE TALKS)
PROGRAM O (SESSIONS 104-109 - MULTIDISCIPLINARY ACUTE STROKE MANAGEMENT; 8:00 A.M. to 3:50 P.M.)
Location: Murray Hill Suites East & West, 2nd Floor
SESSION 104: ACUTE STROKE DECISIONS – TRIAGE AND IMAGING
SESSION 105: STROKE TREATMENT – ADVANCED METHODS AND STANDARDS OF CARE
SESSION 106: HOT TOPICS AND TRENDS 2019
SESSION 107: LUNCHEON SESSION – ATHEROSCLEROSIS, INTRACRANIAL STENTING AND CAROTID STENTING 2019 TRENDING POSITIVE!
SESSION 108: BRAIN ANEURYSM AND VASCULAR MALFORMATIONS
SESSION 109: FUTURE ENDOVASCULAR TREATMENT AND EXPANDING YOUR PRACTICE

Special Non-CME Accredited Activities

Past Programs

2023 | 2022 | 2021 | 2019 | 2018 | 2017 | 2016 |
2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
2008 | 2007 | 2006 | 2005